Results 101 to 110 of about 142,289 (185)

Repurpose

, 2022
Lepelaar, Mark, Oskam, Inge, van Hees, Marco, de Leede, Annelies, van Vorsselen, Jeroen, Diemeer, Manon, Groote Schaarsberg, Nikki   +6 more
openaire   +2 more sources

BioMNEDR: mechanism-guided network embedding for drug repurposing. [PDF]

Brief Bioinform
Zeng Y, Wang L, Liu X.
europepmc   +1 more source

Content for mobile television: issues for a new mass medium within today's ICT environment [PDF]

, 2010
A. Urban, C Andersson, C Coffman, C Sattler, D Nolan, D Steinbock, D. Price, H Bouwman, H Bouwman, J Dijk Van, L Marez De, M McLuhan, R. Scheide, S. Felder, T Ahonen, V Feldmann   +15 more
core   +2 more sources

Impact of drug repurposing between 1985 and 2024 on pharmaceutical innovation. [PDF]

Commun Med (Lond)
Akodad S, Niu X, Secades B, Stevens H.
europepmc   +1 more source

A genetics-guided integrative framework for drug repurposing: identifying antihypertensive drugs for type 2 diabetes. [PDF]

NPJ Drug Discov
Zhong X, Wei Q, Tiwari A, Wang Q, Tan Y, Chen R, Yan Y, Cox NJ, Li B.   +8 more
europepmc   +1 more source

Old Drugs, New Opportunities: Advancing Cancer Care Through Repurposing. [PDF]

United European Gastroenterol J
Williams NR.
europepmc   +1 more source

Repurposing ceritinib [PDF]

Nature Reviews Drug Discovery, 2017
openaire   +1 more source

GARD: Genomic Data-Based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation. [PDF]

Cancers (Basel)
Tanikella P, Nenad W, Courtine C, Dai Y, Deng Q, Zou B, Osazuwa-Peters N, Schrank TP, Wu D.   +8 more
europepmc   +1 more source

Correction: Repurposing cephalosporins as excellent anticancer agents and chemosensitizers for inflammation-driven cancer therapy. [PDF]

Sci Rep
Liu N, Cao W, Tang J, Dong R, Guo J, Luo Z, Yao Q, Teng S, Liang Z, Yang Y, Gu M, Zhou J, Chen W, Liang H, He X.   +14 more
europepmc   +1 more source

Advancing drug development for systemic sclerosis by prioritizing findings from human genetic association studies. [PDF]

Rheumatology (Oxford)
Hughes M, McMahan ZH, Assassai S, Denton CP, Providencia R.   +4 more
europepmc   +1 more source